
Advances in Cancer Research
Free Global Shipping
No minimum orderDescription
The Advances in Cancer Research series provides invaluable information on the exciting and fast-moving field of cancer research. This volume presents outstanding and original reviews on a variety of topics, including Mdm2 - a regulator of cell growth and death; the systematic progression of human cancer; seizing of T-cells by human T-cell leukemia/lymphoma virus type II; host cell dependent expression of latent Epstein-Barr virus genomes; and gene expression profiling of renal cell carcinoma and its implications in diagnosis prognosis and therapeutics.
Key Features
- Provides invaluable information on the exciting and fast-moving field of cancer research.
- Presents outstanding and original reviews on a variety of topics, including Mdm2 - a regulator of cell growth and death; the systematic progression of human cancer; seizing of T-cells by human T-cell leukemia/lymphoma virus type II; host cell dependent expression of latent Epstein-Barr virus genomes; and gene expression profiling of renal cell carcinoma and its implications in diagnosis prognosis and therapeutics
Readership
Researchers and students in the basic and clinical science of cancer biology and oncology, as well as the related areas of genetics, immunology, pharmacology, cell biology, and molecular biology.
Table of Contents
- Mdm2 - A Regulator of Cell Growth and Death
The Systemic Progression of Human Cancer: A Focus on the Individual Disseminated Cancer Cell - The Unit of Selection
Seizing of T-Cells by Human T-Cells Leukemia/Lymphoma Virus Type II
Host Cell Dependent Expression of Latent Epstein-Barr Virus Genomes
Regulation by DNA Methylation
Gene Expression Profiling of Renal Cell Carcinoma and Its Implications in Diagnosis, Prognosis, and Therapeutics
Product details
- No. of pages: 192
- Language: English
- Copyright: © Academic Press 2003
- Published: October 21, 2003
- Imprint: Academic Press
- Hardcover ISBN: 9780120066896
- eBook ISBN: 9780080488233
About the Serial Editor
George Klein
Affiliations and Expertise
Karolinska Insitutet, Stockholm, Sweden
About the Editor
George Vande Woude
Affiliations and Expertise
Director, Van Andel Research Institute, Grand Rapids, MI, USA
NCI-Frederick Cancer Research Facility Frederick, Maryland
ABL-Basic Research Program, NCI-Frederick Cancer Research and Development Center, Frederick, Maryland